Tom Rehwald Now CEO, Tom Legel New CFO
Incyte Diagnostics has promoted Tom Rehwald to Chief Executive Officer. Tom Rehwald has been with Incyte Diagnostics since 2007 as its CFO. Tom has a long and successful history in the health care industry, including being CFO at Spokane ENT Clinic; Director of Corporate Compliance, Director of Internal Audit and Patient Accounts Manager at Providence Health Care.
Tom Rehwald has a Bachelor of Science degree in Business Administration from San Diego State University in San Diego California graduating Summa Cum Laude and became a Certified Public Accountant in California. Tom Rehwald officially took on the CEO role on April 1, 2016 and has great plans to help Incyte Diagnostics grow bigger and stronger.
Incyte Diagnostics has also welcomed Tom Legel as their new Chief Financial Officer. Tom has over twenty years’ experience in complex healthcare organizations. Tom Legel worked for Kootenai Health for over twenty years as their CFO. Tom moved on from Kootenai Health in 2011 and went to Samaritan Healthcare in Moses Lake, WA acting as both their CFO and COO for several years. Most recently Tom was at St. Luke’s Health System in Twin Falls, ID and really looks forward to being a key component of Incyte Diagnostics future growth.
Tom has both his Undergraduate and MBA Graduate degree in Business Administration from Gonzaga University. Tom Legel joined Incyte Diagnostics officially on April 11th, 2016.
About Incyte Diagnostics
Incyte Diagnostics is a private company founded in 1957 by pathologists to provide anatomic diagnostic services in the Pacific Northwest. Incyte Diagnostics is accredited by the College of American Pathologists, the “gold standard” of laboratory accreditation, based on staff qualifications, laboratory equipment, facility safety, testing quality, and overall laboratory management. Laboratories are located in Spokane Valley, Bellevue, Pullman, Yakima and Walla Walla, Washington and are owned and operated by pathologists.
